Intended for healthcare professionals

Feature Investigation

Rivaroxaban: can we trust the evidence?

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i575 (Published 03 February 2016) Cite this as: BMJ 2016;352:i575

Rivaroxaban: can we trust the monitoring device ?

The BMJ must continue its campaign for open access to RCT data, without fear or favour (http://www.bmj.com/content/350/bmj.h3337).

Sadly, in an intensely competitive Pharma world, the companies are unlikely to throw open their most intimate secrets.. but they could confirm how accurately their INR data was lab-validated ??

At least the Rocket-AF triallists have reviewed the effect of the recalled device, thus - http://www.nejm.org/doi/full/10.1056/NEJMc1515842?query=featured_home

Competing interests: No competing interests

05 February 2016
L Sam Lewis
retired GP
NHS
Surgery, Newport, Pembrokeshire SA42 0TJ